查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2032742

全球出血性疾病檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Bleeding Disorder Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 153 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球出血性疾病檢測市場預計將從2025年的1.1452億美元成長至2034年的2.1901億美元，2026年至2034年的複合年成長率（CAGR）為7.47%。該市場正經歷顯著成長，主要原因是血友病和血管性血友病等出血性疾病的盛行率不斷上升。對早期準確診斷日益成長的需求推動了先進檢測技術的應用。人們對這些疾病的認知不斷提高，以及對及時干預重要性的認知不斷增強，進一步促進了已開發市場和新興市場市場的擴張。

關鍵成長要素包括分子檢測和凝血分析儀等診斷技術的進步，這些技術能夠提供更快、更準確的結果。政府加大力度推行旨在改善罕見疾病診斷的措施和醫療保健項目也促進了市場成長。此外，診斷檢查室的擴建和就地檢驗解決方案的普及，也使檢測更加便捷。

隨著自動化程度的提高以及數位醫療技術在診斷流程中的應用日益廣泛，預計未來市場將持續成長。持續的研發投入將帶來更有效率、更經濟的檢測方法。對個人化醫療和預防性醫療保健的日益重視也將進一步推動市場需求。隨著公眾意識的提高和醫療服務可近性的改善，出血性疾病檢測市場預計將實現穩定且長期的成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球出血性疾病檢測市場：依產品分類

  • 市場分析、洞察與預測
  • 試劑和耗材
  • 裝置

第5章 全球出血性疾病檢測市場：依適應症分類

  • 市場分析、洞察與預測
  • A型血友病
  • B型血友病
  • 血管性血友病
  • 特發性血小板減少紫斑症
  • 其他

第6章 全球出血性疾病檢測市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 診斷中心
  • 其他

第7章 全球出血性疾病檢測市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 對中東和非洲市場的分析、洞察和預測。
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Danaher Corporation
    • Grifols SA
    • Abbott Laboratories
    • Roche Diagnostics
    • Sysmex Corporation
    • Novo Nordisk A/S
    • Siemens Healthineers
    • Bio-Rad Laboratories Inc
    • Thermo Fisher Scientific Inc
    • Medtronic Plc
簡介目錄
Product Code: VMR112110310

The global bleeding disorder testing market size is expected to reach USD 219.01 Million in 2034 from USD 114.52 Million in 2025, growing at a CAGR of 7.47 during 2026-2034.This market is experiencing significant growth due to the increasing prevalence of bleeding disorders such as Hemophilia and Von Willebrand Disease. The rising demand for early and accurate diagnosis is driving the adoption of advanced testing technologies. Growing awareness about these conditions and the importance of timely intervention are further contributing to market expansion across both developed and emerging regions.

Key drivers include advancements in diagnostic technologies, such as molecular testing and coagulation analyzers, which provide faster and more accurate results. Increasing government initiatives and healthcare programs aimed at improving rare disease diagnosis are also boosting market growth. Additionally, the expansion of diagnostic laboratories and the availability of point-of-care testing solutions are making testing more accessible.

Looking forward, the market is expected to grow with the integration of automation and digital health technologies in diagnostic processes. Continuous research and development will lead to more efficient and cost-effective testing methods. Increasing focus on personalized medicine and preventive healthcare will further drive demand. As awareness and accessibility improve, the bleeding disorder testing market is poised for consistent and long-term growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

  • Reagents & Consumables
  • Instruments

By Indication

  • Hemophilia A
  • Hemophilia B
  • Von Willebrand Disease
  • Idiopathic Thrombocytopenic Purpura
  • Others

By End-use

  • Hospitals And Clinics
  • Diagnostic Centers
  • Others

COMPANIES PROFILED

  • Danaher Corporation, Grifols S.A., Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Novo Nordisk A/S, Siemens Healthineers, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Medtronic plc

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BLEEDING DISORDER TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLEEDING DISORDER TESTING MARKET: BY INDICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Indication
  • 5.2. Hemophilia A Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Hemophilia B Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Von Willebrand Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Idiopathic Thrombocytopenic Purpura Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLEEDING DISORDER TESTING MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BLEEDING DISORDER TESTING MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Indication
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Indication
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Indication
    • 7.4.3 By End-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Indication
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Indication
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BLEEDING DISORDER TESTING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Danaher Corporation
    • 9.2.2 Grifols S.A
    • 9.2.3 Abbott Laboratories
    • 9.2.4 Roche Diagnostics
    • 9.2.5 Sysmex Corporation
    • 9.2.6 Novo Nordisk A/S
    • 9.2.7 Siemens Healthineers
    • 9.2.8 Bio-Rad Laboratories Inc
    • 9.2.9 Thermo Fisher Scientific Inc
    • 9.2.10 Medtronic Plc